Live Breaking News & Updates on News Ratings For Jazz Pharmaceuticals Daily

Stay updated with breaking news from News ratings for jazz pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CAO Patricia Carr Sells 163 Shares

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) CAO Patricia Carr sold 163 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $108.83, for a total value of $17,739.29. Following the transaction, the chief accounting officer now owns 6,596 shares in the company, […] ....

United States , Piper Sandler , Patricia Carr , Royal Bank , Armistice Capital , Cantor Fitzgerald , Hedge Funds Weigh In On Jazz Pharmaceuticals , Aristotle Capital Management , Quarter For Jazz Pharmaceuticals , Pacer Advisors Inc , Jazz Pharmaceuticals Stock Performance , Jpmorgan Chase Co , Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Get Free Report , World Investors , Point Capital , Jazz Pharmaceuticals Daily ,

Avidity Partners Management LP Sells 308,381 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Avidity Partners Management LP lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals […] ....

United States , Neenam Patil , News Ratings For Jazz Pharmaceuticals Daily , Jpmorgan Chase Co , Pathstone Family Office , Vanguard Personalized Indexing Management , Jazz Pharmaceuticals Profile , Cantor Fitzgerald , Jazz Pharmaceuticals , Royal Bank , Needham Company , Securities Exchange Commission , Insider Activity At Jazz Pharmaceuticals , Jazz Pharmaceuticals Stock , Charles Schwab Investment Management Inc , Janney Montgomery Scott , Quarter For Jazz Pharmaceuticals , Goldman Sachs Group , Avidity Partners Management , Free Report , Partners Management , Wealth Management , Montgomery Scott , Schwab Investment Management , Personalized Indexing Management , Get Free Report ,

Avidity Partners Management LP Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Avidity Partners Management LP cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals makes up approximately 2.2% of Avidity Partners Management LP’s […] ....

United States , Neenam Patil , Stifel Nicolaus , Piper Sandler , Holdings Channel , Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Jpmorgan Chase Co , International Assets Investment Management , Polaris Capital Management , Dynamic Technology Lab Private Ltd , Quarter For Jazz Pharmaceuticals , Baupost Group , Jazz Pharmaceuticals Stock , Desjardins Global Asset Management Inc , Avidity Partners Management , Free Report , Partners Management , Capital Management , Technology Lab Private Ltd , Assets Investment Management , Desjardins Global Asset Management , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily ,

RK Capital Management LLC Reduces Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

RK Capital Management LLC trimmed its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 34.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 92,020 shares of the specialty pharmaceutical company’s stock after selling 48,875 shares during the period. […] ....

United States , Neenam Patil , Patricia Carr , Piper Sandler , Stifel Nicolaus , Pacer Advisors Inc , Vanguard Group Inc , Insider Transactions At Jazz Pharmaceuticals , Securities Exchange Commission , Exchange Commission , Jazz Pharmaceuticals , Jazz Pharmaceuticals Stock Performance , Jpmorgan Chase Co , Quarter For Jazz Pharmaceuticals , Polaris Capital Management , Jazz Pharmaceuticals Profile , News Ratings For Jazz Pharmaceuticals Daily , Ameriprise Financial Inc , York Capital Management , Free Report , Capital Management , Pacer Advisors , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily ,

StockNews.com Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to Strong-Buy

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […] ....

United States , Patricia Carr , Neenam Patil , Stifel Nicolaus , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals Trading Down , News Ratings For Jazz Pharmaceuticals Daily , Covestor Ltd , Royal Bank , Cantor Fitzgerald , Jazz Pharmaceuticals , Institutional Investors Weigh In On Jazz Pharmaceuticals , Insider Transactions At Jazz Pharmaceuticals , Rise Advisors , Analyst Recommendations For Jazz Pharmaceuticals , Cape Investment Advisory Inc , Get Free Report , Pharmaceuticals Trading Down , Investment Advisory , Wealth Management , Jazz Pharmaceuticals Daily ,